Number of cell therapies in development by strategy 2019-2021
This statistic depicts the number of select types of cellular immunotherapies being developed globally in 2019, 2020, and 2021, including all phases from preclinical through approval and marketed products. Most of the therapies used chimeric antigen receptor T-cells (CAR-T).